Kind Patches Dopamine Lawsuit, Were You Affected? Maggi v. Kind Patches Limited, No. 1:26-cv-01466

If you bought Kind’s “Dopamine Patches” believing they’d deliver an actual neurotransmitter through your skin — you were not imagining the marketing. A proposed class action filed in the Northern District of New York, Maggi, et al. v. Kind Patches Limited, No. 1:26-cv-01466, claims the patches contain herbal extracts, not dopamine, and can’t do what the name promises. Here’s what that means for you.

Kind Patches Dopamine Lawsuit — Key Facts

Detail	Information
Lawsuit Filed	2026 — exact filing date UNVERIFIED; case is docketed under No. 1:26-cv-01466-MAD-DJS
Defendant	Kind Patches Limited
Alleged Harm	False advertising — patches marketed as “Dopamine Patches” (later rebranded “Mood+ Patches”) allegedly contain no dopamine, only herbal ingredients
Law Alleged	California Unfair Competition Law, False Advertising Law, and Consumers Legal Remedies Act; New York General Business Law; unjust enrichment
Who Is Affected	Consumers who purchased Kind Dopamine Patches, also sold under the name “Mood+ Patches (Formerly Dopamine)”
Court & Case Number	U.S. District Court, Northern District of New York, No. 1:26-cv-01466-MAD-DJS
Current Stage	Complaint filed; no class has been certified and no ruling has been made on the merits
Lead Plaintiff Deadline	N/A — this is a consumer false-advertising case, not a securities class action
Settlement Status	No settlement. The case is active.
Last Updated	September 4, 2026

Who Is Kind Patches and Why Are They Being Sued for This?

Kind Patches Limited sells adhesive wellness patches online, marketed as a needle-free way to support mood, focus, and other health goals. The company built its “Dopamine Patches” around one specific promise — a named brain chemical, delivered through the skin — which is precisely the claim the lawsuit says can’t hold up once you read the ingredient list.

What Did Kind Patches Do Between Early 2025 and Now?

The complaint alleges Kind Patches marketed its product as containing dopamine, or working like a dopamine agonist, when the actual ingredients are herbal: mucuna pruriens extract, 5-HTP, lion’s mane mushroom extract, and rhodiola extract. None of those is the dopamine molecule itself. According to the complaint, that gap is the whole case: “[Kind’s] representations that its patches contain ‘dopamine’ and will work as advertised is nothing but a sham because the herbal ingredients in the patches are not as effective at providing the same benefits as the actual dopamine chemical or a dopamine agonist via transdermal delivery.”

Plaintiffs bring claims under three separate California consumer-protection statutes plus New York’s General Business Law — laws that all target the same basic conduct: telling shoppers a product does something it can’t, and getting paid for it anyway.

To see how a case like this typically moves from filed complaint toward resolution, our guide to joining a class action lawsuit covers what usually happens next and when, if ever, class members need to act.

This isn’t Kind Patches’ only false-advertising fight. A separate 2025 lawsuit accuses the company of falsely claiming its unrelated GLP-1 patches can raise natural GLP-1 levels the way an actual GLP-1 drug does — a claim that echoes the same pattern: a trendy biological term on the label, herbal ingredients underneath it.

Are You Part of the Kind Patches Dopamine Lawsuit?

Here’s exactly how to know if this case includes you.

• Anyone who purchased Kind’s Dopamine Patches, under that name or as “Mood+ Patches (Formerly Dopamine)”
• Purchases made since early 2025, when the product was first sold under the dopamine branding
• Buyers in California and New York have specific state-law claims pled in the complaint; a nationwide class is also proposed
• People who bought the separate GLP-1 patches are not covered by this case — that’s a different lawsuit with its own docket number

You do not need to have experienced a specific health outcome to potentially qualify. This is a false-advertising claim about what you paid for, not a product-injury claim about what happened to you physically.

Kind Patches Buyers Outside California and New York — Are You Still Covered?

The complaint proposes both state-specific classes (California and New York) and a broader nationwide class, since Kind Patches sold the product across the U.S. Whether a nationwide class gets certified is still undecided — that determination hasn’t been made yet.

Not sure if you qualify for the Kind Patches dopamine lawsuit? A free consultation with a consumer fraud attorney can help you understand where your purchase fits while the case is still active.

What Are Kind Patches Buyers Asking the Court to Award?

The plaintiffs are seeking a jury trial, declaratory and injunctive relief, and monetary damages for themselves and the proposed class — including unjust enrichment claims tied to what Kind Patches was paid for a product plaintiffs say couldn’t deliver on its central promise.

No money yet. No claim form yet. Nothing here should be read as a payout guide, because there isn’t one to guide anyone through.

What Could Kind Patches Buyers Receive If This Settles?

Impossible to predict at this stage. It depends on how many people join the class, what evidence develops during discovery, and how any settlement or trial verdict gets negotiated or decided. If you believe your individual losses are unusually high — say, you bought in bulk or relied on the claims for a specific health decision — a consumer fraud attorney can help you weigh an individual claim against staying in the proposed class.

What Should Kind Patches Buyers Do Right Now?

1. Most buyers are automatically potential class members. No action is required to preserve your rights at this stage.
2. Save your receipt, order confirmation, or credit card statement showing the purchase, along with the packaging or product listing if you still have it
3. Note approximately when you bought the patches and whether it was the “Dopamine Patches” or “Mood+ Patches” branding
4. This case has no lead plaintiff deadline to track, since it isn’t a securities matter — there’s no clock running on your ability to stay informed
5. Monitor the docket in the Northern District of New York under No. 1:26-cv-01466-MAD-DJS for developments like class certification
6. If you’re considering pursuing your own individual lawsuit instead of joining the class, talk to a consumer fraud attorney before making that decision — it typically only makes sense if your losses are significantly above the average purchase price

Kind Patches also faces a separate lawsuit over its GLP-1 patches, filed in the Eastern District of New York in late 2025. If you’re trying to understand where patch-based supplement claims fit against the much larger, drug-based GLP-1 litigation landscape, our GLP-1 weight loss drug lawsuit update explains how that separate, much larger litigation against Novo Nordisk and Eli Lilly actually works — it’s a different kind of case entirely from the advertising claims here.

Kind Patches Dopamine Lawsuit — Full Timeline

Milestone	Date
Kind Dopamine Patches marketed and sold	Since early 2025
UK Advertising Standards Authority rules Kind’s ads misleading	February 4, 2026
Separate GLP-1 patches lawsuit filed against Kind Patches	Filed in the Eastern District of New York, 2025
Dopamine patches lawsuit filed	2026 — exact date UNVERIFIED; docketed as No. 1:26-cv-01466-MAD-DJS
Next scheduled hearing	UNVERIFIED — no hearing date published as of this writing
Expected resolution	UNVERIFIED — case is in its early stages

Kind Patches Dopamine Lawsuit — Frequently Asked Questions, No. 1:26-cv-01466

Is there a class action lawsuit against Kind Patches for its dopamine claims right now?

 Yes. Maggi, et al. v. Kind Patches Limited, No. 1:26-cv-01466, is pending in the U.S. District Court for the Northern District of New York, alleging the company’s Dopamine Patches don’t contain dopamine.

Do I need to do anything right now to be part of the Kind Patches lawsuit?

 No. There’s no claim form and no deadline at this stage. If a class is certified and the case resolves in plaintiffs’ favor, you’ll be notified through the standard class action notice process.

When will the Kind Patches dopamine case settle? 

UNVERIFIED. The case is still in its early stages, with no class certified and no trial or settlement date set.

Can I file my own lawsuit against Kind Patches instead of joining the class?

 Yes, that’s an option, particularly if your individual purchases or losses are significantly higher than a typical class member’s. A consumer fraud attorney can help you weigh that against staying in the proposed class.

How will I find out if the Kind Patches lawsuit settles? 

If the case settles or a class is certified, notice typically goes out by mail or email to identifiable purchasers, along with public notice through a settlement website. Bookmark this page — we’ll update it when that happens.

What specific laws does Kind Patches allegedly violate?

 The complaint cites California’s Unfair Competition Law, False Advertising Law, and Consumers Legal Remedies Act, New York’s General Business Law, and a common-law unjust enrichment claim.

How much could Kind Patches buyers get if this case settles?

 UNVERIFIED. No settlement exists, and it’s far too early to estimate a payout. Any specific dollar figure at this stage would be a guess, not a fact.

Is the GLP-1 patches lawsuit against Kind Patches the same case?

 No. That’s a separate lawsuit over different products and different claims — that Kind Patches falsely advertised its GLP-1 patches as boosting natural GLP-1 levels comparable to prescription GLP-1 medications. It has its own docket number and proceeds independently of this dopamine patches case.

Sources Used in This Kind Patches Dopamine Lawsuit Article

• U.S. District Court for the Northern District of New York — Maggi, et al. v. Kind Patches Limited, Case No. 1:26-cv-01466-MAD-DJS

Note on Verification

The exact filing date of the complaint was not confirmed from a named primary source available at the time of writing and is marked UNVERIFIED rather than estimated. The specific purchase details attributed to the lead plaintiff in some secondary coverage of this case were not independently verifiable against a primary court source and have been left out of this article rather than repeated as fact. This article does not cite ClassAction.org, TopClassActions.com, or other competitor aggregator coverage of this case, consistent with this site’s sourcing standards.

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the case docket for Maggi, et al. v. Kind Patches Limited, No. 1:26-cv-01466-MAD-DJS, as of September 4, 2026. Last Updated: September 4, 2026.

This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.